Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders

Fig. 2

Median anti-SARS-CoV-2 IgG-reactive antibody titers measured in binding antibody units/mL (BAU/mL) at 3–6 weeks after the 2nd dose according to SARS-CoV-2 breakthrough infection. Patients who did not developed SARS-CoV-2 infection (n = 1207) had a median of 730.81 BAU/mL (range 0–58,600) vs 1.83 BAU/mL (range 0–4854.93) in those who did develop breakthrough infection (n = 27) (p = 0.007)

Back to article page